Product: GINSENG KIANPI PIL, 60 capsules, PRODUCT OF KWEILIN DRUG MANUFACTORY
Reason for recall: Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.
Recall initiated: 20141120
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated